Research & Development
Biosync has a long term commitment to developing Generics with the help of world class research and high quality standards. Our research and development team consists of scientists and developers who are highly qualified and experienced in formulation and analytical development. Our focus remains on continuing to develop new formulations in various dosage forms including Solid Dosage, Liquid Dosage, Injectables, Protein Powders ,Nutraceutical , Herbal Pellets etc
Biosync believes in creating a niche in the pharmaceutical industry around the globe by developing and delivering products at an affordable price. With the team of dedicated research scientist,Biosync has been efficacious in accomplishment of the company goals in terms of new product development, Scale up, technology transfer to commercial manufacturing and supply management of pharmaceutical products. Constant efforts of our team of scientist who are always determined to examine the drugs from laboratory scale batch to commercial batch. Our team of experts is completely focusing on prior tests starting from pilot testing to technological transfers.
Biosync is committed to developing Generics in the long term, employing world-class research and high-quality standards. Our research and development team consists of highly skilled and experienced scientists and developers who specialize in formulation and analytical development. We continue to focus on advancing new formulations across a range of dosage forms including Solid Dosage, Liquid Dosage, Injectables, Protein Powders, Nutraceuticals, Herbal Pellets, and more.
Biosync seeks to establish a niche in the global pharmaceutical sector by creating and supplying products at an affordable price. With a dedicated team of research scientists, Biosync has successfully achieved the company’s objectives related to new product development, scale-up, technology transfer to commercial manufacturing, and pharmaceutical product supply management. The ongoing efforts of our team of scientists are directed toward analyzing drugs from laboratory-scale batches to commercial batches. Our team of experts is entirely focused on preliminary tests, ranging from pilot testing to technology transfers.
